Detalles de la búsqueda
1.
POLD1 as a Prognostic Biomarker Correlated with Cell Proliferation and Immune Infiltration in Clear Cell Renal Cell Carcinoma.
Int J Mol Sci
; 24(7)2023 Apr 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-37047824
2.
SAA1 Has Potential as a Prognostic Biomarker Correlated with Cell Proliferation, Migration, and an Indicator for Immune Infiltration of Tumor Microenvironment in Clear Cell Renal Cell Carcinoma.
Int J Mol Sci
; 24(8)2023 Apr 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-37108666
3.
LINC00941 Promotes Cell Malignant Behavior and Is One of Five Costimulatory Molecule-Related lncRNAs That Predict Prognosis in Renal Clear Cell Carcinoma.
Medicina (Kaunas)
; 59(2)2023 Jan 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-36837389
4.
Management of Primary Female Urethral Adenocarcinoma: Two Rare Case Reports and Literature Review.
Medicina (Kaunas)
; 59(1)2023 Jan 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-36676733
5.
Bioinformatics Prediction and Experimental Verification Identify CAB39L as a Diagnostic and Prognostic Biomarker of Kidney Renal Clear Cell Carcinoma.
Medicina (Kaunas)
; 59(4)2023 Apr 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-37109674
6.
Cystic renal cell carcinoma: a report of 67 cases including 4 cases with concurrent renal cell carcinoma.
BMC Urol
; 14: 87, 2014 Nov 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-25381150
7.
Identification of a cisplatin resistant-based prognostic immune related gene signature in MIBC.
Transl Oncol
; 44: 101942, 2024 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-38555741
8.
RCC1 functions as a tumor facilitator in clear cell renal cell carcinoma by dysregulating cell cycle, apoptosis, and EZH2 stability.
Cancer Med
; 12(19): 19889-19903, 2023 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-37747077
9.
SETD2 Deficiency Confers Sensitivity to Dual Inhibition of DNA Methylation and PARP in Kidney Cancer.
Cancer Res
; 83(22): 3813-3826, 2023 11 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-37695044
10.
Activation of cGAS-STING Signal to Inhibit the Proliferation of Bladder Cancer: The Immune Effect of Cisplatin.
Cells
; 11(19)2022 09 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-36230972
11.
Albumin levels predict prognosis in advanced renal cell carcinoma treated with tyrosine kinase inhibitors: a systematic review and meta-analysis.
Urol Oncol
; 40(1): 12.e13-12.e22, 2022 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34454823
12.
Population-based outcome of muscle-invasive bladder cancer following radical cystectomy: who can benefit from adjuvant chemotherapy?
Transl Androl Urol
; 10(1): 356-373, 2021 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-33532324
13.
Microfluidic Assaying of Circulating Tumor Cells and Its Application in Risk Stratification of Urothelial Bladder Cancer.
Front Oncol
; 11: 701298, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34178700
14.
A Novel DNA Methylation Signature as an Independent Prognostic Factor in Muscle-Invasive Bladder Cancer.
Front Oncol
; 11: 614927, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-33659216
15.
Mitofusin-2 is a novel direct target of p53.
Biochem Biophys Res Commun
; 400(4): 587-92, 2010 Oct 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-20804729
16.
Urinary exfoliated tumor single-cell metabolomics technology for establishing a drug resistance monitoring system for bladder cancer with intravesical chemotherapy.
Med Hypotheses
; 143: 110100, 2020 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-32721798
17.
CDCA5 functions as a tumor promoter in bladder cancer by dysregulating mitochondria-mediated apoptosis, cell cycle regulation and PI3k/AKT/mTOR pathway activation.
J Cancer
; 11(9): 2408-2420, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-32201512
18.
Survival after radical cystectomy for bladder cancer: Multicenter comparison between minimally invasive and open approaches.
Asian J Urol
; 7(3): 291-300, 2020 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-32742929
19.
Modulation of G6PD affects bladder cancer via ROS accumulation and the AKT pathway in vitro.
Int J Oncol
; 53(4): 1703-1712, 2018 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-30066842
20.
Detection of Urothelial Bladder Carcinoma via Microfluidic Immunoassay and Single-Cell DNA Copy-Number Alteration Analysis of Captured Urinary-Exfoliated Tumor Cells.
Cancer Res
; 78(14): 4073-4085, 2018 07 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-29789419